Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed multicomponent method for carbonyl-bridged biheterocycles. Safe, efficient synthesis avoiding toxic CO gas for reliable pharmaceutical intermediate supply.
Patent CN115353511A details a novel Pd-catalyzed multicomponent route for carbonyl-bridged biheterocycles, offering safer processing and cost reduction in API manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN102260129A reveals a mild N-heterocyclic carbene catalyzed esterification. This technology offers significant cost reduction in ester manufacturing and enhanced supply chain reliability.
Patent CN113307778A reveals a mild Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112125843B reveals a green Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN108727179B details a novel one-pot allylation-Wittig reaction using allylic alcohols. This method offers significant cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Patent CN112480015B details a one-pot Pd-catalyzed method for quinazolinones, offering high yields and broad substrate scope for pharma intermediates.
Patent CN102766095A reveals a mild base-catalyzed route for electron-deficient pyrazoles, offering high yields and superior regioselectivity for pharmaceutical intermediate manufacturing.
Patent CN115353511A reveals a safe, one-pot Pd-catalyzed method for carbonyl-bridged biheterocycles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112812122B reveals a novel oxidative method for producing beta-indole carbonyls and pyranoindoles with high yield and mild conditions for reliable supply.
Patent CN113105402A reveals a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN112480015B details a novel Pd-catalyzed one-pot method for quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN107118145B details a green Pd-organic nitrite co-catalyzed cyclization. This method offers significant cost reduction in API manufacturing by eliminating toxic co-oxidants.
Advanced Rhodium-catalyzed synthesis of trifluoromethyl enaminones per CN118619879A. Offers cost-effective, scalable routes for complex heterocyclic drug intermediates.
Patent CN113307778A reveals a mild Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Patent CN107382769B reveals a low-cost synthesis route for trifluoromethyl azides. This method enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN110724080B details a green electrochemical route using arylboronic acids, offering high yields and reduced costs for pharmaceutical intermediate manufacturing.
Novel carbonylation method avoids toxic thiols using sulfonyl chlorides. High yield, scalable process ideal for reliable pharmaceutical intermediate manufacturing.